<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Clinical and genetic characterization of PYROXD1‐related myopathy patients from Turkey

Loading...
Thumbnail Image

Institution Authors

Organizational Units

Organizational Units

Advisor

Editor

Journal Title

Journal ISSN

Volume Title

Type:

Publisher

Wiley

DOI

10.1002/ajmg.a.62148

Abstract

AbstractCongenital myopathies (CMs) are a heterogeneous group of inherited muscle disorders characterized by muscle weakness at birth, while limb‐girdle muscular dystrophies (LGMD) have a later onset and slower disease progression. Thus, detailed clinical phenotyping of genetically defined disease entities are required for the full understanding of genotype–phenotype correlations. A recently defined myopathic genetic disease entity is caused by bi‐allelic variants in a gene coding for pyridine nucleotide‐disulfide oxidoreductase domain 1 (PYROXD1) with unknown substrates. Here, we present three patients from two consanguineous Turkish families with mild LGMD, facial weakness, normal CK levels, and slow progress. Genomic analyses revealed a homozygous known pathogenic missense variant (c.464A&gt;G, p.Asn155Ser) in family 1 with two affected females. In the affected male of family 2, we found this variant in a compound heterozygous state together with a novel frameshift variant (c.329_332delTCTG, p.Leu112Valfs*8), which is the second frameshift variant known so far in PYROXD1. We have been able to define a large homozygous region in family 1 sharing a common haplotype with family 2 in the critical region. Our data suggest that c.464A&gt;G is a Turkish founder mutation. To gain deeper insights, we performed a systematic review of all published PYROXD1‐related myopathy cases. Our analysis showed that the c.464A &gt; G variant was found in 87% (20/23) of the patients and that it may cause either a childhood‐ or adult‐onset phenotype, irrespective of its presence in a homozygous or compound heterozygous state. Interestingly, only four patients had elevated CK levels (up to 1000 U/L), and cardiac involvement was found in few compound heterozygous cases.

Description

Journal or Series

American Journal of Medical Genetics Part A

ISSN

1552-4825

ISBN

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By

Rights and licensing

info:eu-repo/semantics/openAccess

Research Projects

Journal Issue

Related Patent

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators